MARS treatment in posthepatectomy liver failure

被引:36
作者
van de Kerkhove, MP
de Jong, KP
Rijken, AM
de Pont, ACJM
van Gulik, TM
机构
[1] Univ Amsterdam, Acad Med Ctr, Surg Lab IWO 1 172, Dept Surg, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Groningen, Univ Hosp, Dept Hepatopancreatobiliary Surg & Liver Transpla, Groningen, Netherlands
[3] Amphia Hosp, Dept Surg, Breda, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands
关键词
hepatectomy; liver resection; liver; liver failure; liver support; MARS; survival;
D O I
10.1034/j.1478-3231.23.s.3.2.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Posthepatactomy liver failure (PHLF) is a dramatic complication following extensive liver resection or liver resection in a compromised liver, leading to death in 80% of cases. Molecular Adsorbent Recirculating System (MARS) is able to extract water and protein bound toxins out of the blood in liver failure patients. This paper describes the initial experience in the Netherlands using the MARS liver assist device in five patients with PHLF. In all patients, improvement of biochemical parameters was observed during MARS treatments along with clinical improvement in three patients. One patient survived. No clear guidelines for MARS treatment and prognostic factors for outcome after MARS treatment with regard to this patient group are available. In this paper, a MARS treatment regimen for PHLF is suggest based on literature and our experience.
引用
收藏
页码:44 / 51
页数:8
相关论文
共 28 条
[1]  
[Anonymous], 1979, The Hepatic Coma Syndromes and Lactulose
[2]  
BOZZETTI F, 1992, HEPATO-GASTROENTEROL, V39, P237
[3]   Surgical treatment of malignant liver tumours [J].
DeMatteo, RP ;
Fong, YM ;
Blumgart, LH .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 1999, 13 (04) :557-574
[4]  
DINANT S, 2002, UNPUB FLEXICOR STUDY
[5]   Risk of major liver resection in patients with underlying chronic liver disease - A reappraisal [J].
Farges, O ;
Malassagne, B ;
Flejou, JF ;
Balzan, S ;
Sauvanet, A ;
Belghiti, J .
ANNALS OF SURGERY, 1999, 229 (02) :210-215
[6]   COEXPRESSION OF LIVER-SPECIFIC AND GROWTH-INDUCED GENES IN PERINATAL AND REGENERATING LIVER - ATTAINMENT AND MAINTENANCE OF THE DIFFERENTIATED STATE DURING RAPID PROLIFERATION [J].
HABER, B ;
NAJI, L ;
CRESSMAN, D ;
TAUB, R .
HEPATOLOGY, 1995, 22 (03) :906-914
[7]   APACHE III, unlike APACHE II, predicts posthepatectomy mortality in patients with biliary tract carcinoma [J].
Hamahata, N ;
Nagino, M ;
Nimura, Y .
CRITICAL CARE MEDICINE, 1998, 26 (10) :1671-1676
[8]   Liver transplantation for hepatocellular carcinoma [J].
Hemming, AW ;
Cattral, MS ;
Reed, AI ;
Van der Werf, WJ ;
Greig, PD ;
Howard, RJ .
ANNALS OF SURGERY, 2001, 233 (05) :652-658
[9]  
Hwang EH, 1999, J NUCL MED, V40, P1644
[10]   Improvement in Perioperative outcome after hepatic resection - Analysis of 1,803 consecutive cases over the past decade [J].
Jamagin, WR ;
Gonen, M ;
Fong, YM ;
DeMatteo, RP ;
Ben-Porat, L ;
Little, S ;
Corvera, C ;
Weber, S ;
Blumgart, LH .
ANNALS OF SURGERY, 2002, 236 (04) :397-407